Plasma 3,3’,5-Triiodo-L-thyronine [T3] level mirrors changes in tumor markers in two cases of metastatic cancer of the breast and pancreas treated with exogenous L-T3

Preclinical studies have attributed 3,3’,5-triiodo-L-thyronine (T3) a direct negative effect on tumor progression, as well as chemosensitizing, differentiating and immunomodulatory properties. On the other hand, L-thyroxine (T4), via a thyroid hormone receptor on plasma membrane integrin [Formula: s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Molinero, Alejandro, Hercbergs, Aleck, Sarrias, Manuel, Yuste, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859424/
https://www.ncbi.nlm.nih.gov/pubmed/29125479
http://dx.doi.org/10.3233/CBM-170668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859424/
https://www.ncbi.nlm.nih.gov/pubmed/29125479
http://dx.doi.org/10.3233/CBM-170668

Ejemplares similares